Thrombolytic treatment for recurrent myocardial infarction.
- 23 February 1991
- Vol. 302 (6774), 429-430
- https://doi.org/10.1136/bmj.302.6774.429
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.Heart, 1990
- GISSI-2 and the heparin controversyThe Lancet, 1990
- Reinfarction after thrombölytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smokingJournal of the American College of Cardiology, 1990
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Antistreptokinase titres after intravenous streptokinaseThe Lancet, 1990
- Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial InfarctionNew England Journal of Medicine, 1989
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Assessment of Anti-Streptokinase Antibody Levels in Human Sera Using a Microradioimmunoassay ProcedureThrombosis and Haemostasis, 1984
- Thrombolytic Therapy with Streptokinase Using a Standard Dosage SchemeBMJ, 1966